Analysis of Trade Management in China's Pharmaceutical Industry in the Context of RCEP

Abstract

At present, in the face of complex internal and external situations, the regional trade dynamics stimulated by the entry into force of the Regional Comprehensive Economic Partnership Agreement (RCEP) is adding steady growth momentum to China's pharmaceutical exports. This paper summarises the development opportunities for China's pharmaceutical exports from the current situation of China's pharmaceutical industry exports, in the context of RCEP, and then discusses the current problems of China's pharmaceutical industry exports from the aspects of product export structure, and puts forward relevant management advice for enterprises and the government.